Skip to main content

Advertisement

SpringerLink
Log in

Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease?

  • Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Breast cancers (BCs) are the most common malignancies among women worldwide. Giving birth to a first child before 24 years of age decreases the BC risk by about half, when women reach menopausal years. The scientific evidence suggests that the actions of human chorionic gonadotropin (hCG) are responsible for this decrease. Human BC cells and tissues contain hCG/luteinizing hormone receptors. The activation of the receptors results in an increase in cell differentiation and apoptosis. Conversely, it decreases the cell proliferation, invasion, and survival. The hCG actions are primarily cyclic adenosine monophosphate/protein kinase A mediated, require the presence of receptors, and involve blocking the activation and nuclear translocation of the transcription factor, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB). The women with a higher hCG levels during pregnancy tend to have a lower BC incidence and those with the receptor-positive tumors have a longer metastasis-free survival. The long-term benefits of pregnancy/hCG seem to come from permanent signature genomic imprinting and expression changes, which are characterized by low cell proliferation, increased efficiency of DNA repair mechanisms, cell differentiation, and cells resistance to carcinogenesis. These findings could provide clinical opportunities to use hCG for the prevention of BC in this modern era of increasing number of young women in our societies waiting longer than ever to have their first child. In addition, hCG may be useful to reduce and/or eliminate cellular targets of carcinogenic changes during an active ongoing disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 2000;50(1):7–33.

    Article  CAS  PubMed  Google Scholar 

  2. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133–140.

    Article  CAS  PubMed  Google Scholar 

  3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  4. American Cancer Society. Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society; 201

  5. Breast cancer prevention and control. http://www.whoint/cancer/detection/breastcancer/en//index1.html. Published 2016.

  6. Carlson HW, Kane P, Lei ZM, Li X, Rao CV. Presence of luteinizing hormone/human chorionic gonadotropin receptors in male breast tissues. J Clin Endocrinol Metab. 2004;89(8):4119–4123.

    Article  CAS  PubMed  Google Scholar 

  7. Glick PC. Updating the life cycle of the family. J Marriage Fam. 1977;39:5–13.

    Article  Google Scholar 

  8. Average age of first-time moms climbing in the US. http://www.npr.org/sections-shots/2016/01/14/462816458. Published 2016.

  9. MacMahon B, Cole P, Lin TM, et al. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43(2):209–221.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. MacMahon B, Purde M, Cramer D, Hint E. Association of breast cancer risk with age at first and subsequent births: a study in the population of the Estonian Republic. J Natl Cancer Inst. 1982;69(5):1035–1038.

    CAS  PubMed  Google Scholar 

  11. Trapido EJ. Age at first birth, parity and breast cancer risk. Cancer. 1983;51(5):946–948.

    Article  CAS  PubMed  Google Scholar 

  12. Trichopoulos D, Hsien C, MacMahon B, et al. Age at any birth and breast cancer risk. Int J Cancer. 1983;31(6):701–704.

    Article  CAS  PubMed  Google Scholar 

  13. Kvale G, Heuch I. A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am J Epidemiol. 1987;126(5):842–850.

    Article  CAS  PubMed  Google Scholar 

  14. Negri E, la Vecchia C, Duffy SW, Bruzzi P, Parazzini F, Day NE. Age at first and second births and breast cancer risk in biparous women. Int J Cancer. 1990;46:972–975.

    Article  Google Scholar 

  15. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47.

    Article  CAS  PubMed  Google Scholar 

  16. Kalache A, Maguire A, Thompson SG. Age at last full-term pregnancy and risk of breast cancer. Lancet. 1993;314:32–35.

    Google Scholar 

  17. MacMahon B. Reproduction and cancer of the breast. Cancer. 1993;71:83–88

    Article  Google Scholar 

  18. Chie WC, Hsieh CC, Newcomb PA, et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol. 2000;151(7):715–722.

    Article  CAS  PubMed  Google Scholar 

  19. Rao CV. Does full term pregnancy at a young age protect women against breast cancer through hCG? Obstet Gynecol. 2000;96(5 pt 1):783–786.

    CAS  PubMed  Google Scholar 

  20. Lagiou A, Lagiou P, Vassilarou DS, Stoikidou M, Trichopoulos D. Comparison of age at first full-term pregnancy between women with breast cancer and women with benign breast diseases. Int J Cancer. 2003;107(5):817–821.

    Article  CAS  PubMed  Google Scholar 

  21. Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res. 2004;10(1 pt 2):380–345.

    Article  Google Scholar 

  22. Lord SJ, Bernstein L, Johnson KA, et al. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemol Biomarkers Prev. 2008;17(7):1723–1730.

    Article  CAS  Google Scholar 

  23. Lukanova A, Andersson R, Wulff M, et al. Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemol. 2008;168(11):1284–1291.

    Article  Google Scholar 

  24. Toniolo P, Grankvist K, Wulff M, et al. Human chorionic gona-dotropin in pregnancy and maternal risk of breast cancer. Cancer Res. 2010;70(17):6779–6786.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kroman N, Jensen MB, Melbye M, Wohlfart J, Mouridsen HT. Should women be advised against pregnancy after breast-cancer treatment? Lancet. 1997;350(9074):319–322.

    Article  CAS  PubMed  Google Scholar 

  26. Callihan EB, Gao D, Jindal S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat. 2013;138(2):549–559.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Iezzi M, Quaglino E, Cappello P, et al. hCG hastens both the development of mammary carcinoma and the matastatization of hCG. LH and ERBB-2 receptor-positive cells in mice. Int J Immunopathol Pharmacol. 2011;24(3):621–630.

    Article  CAS  PubMed  Google Scholar 

  28. Barton M, Santucci-Pereira J, Russo J. Molecular pathways involved in pregnancy-induced prevention against breast cancer. Frontiers Endocrinol (Lausanne). 2014;5:213.

    Article  Google Scholar 

  29. Lei ZM, Rao CV. Endocrinology of the trophoblast tissue. In: Becker K, ed. Principles and Practice of Endocrinology and Metabolism. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1096–1102.

    Google Scholar 

  30. Licht P, Cao H, Lei ZM, Rao CV, Merz WE. Novel self-regulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta. Endocrinology. 1993;133(6):3014–3025.

    Article  CAS  PubMed  Google Scholar 

  31. Russo J, Russo I. Biological and molecular basis of mammary carcinogenesis. Lab Invest. 1987;57(2):112–137.

    CAS  PubMed  Google Scholar 

  32. Russo I, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996;104(9):938–967.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Sinha DK, Pazik JE, Dao TL. Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Br J Cancer. 1988;57(4):390–394.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005;7(3):131–142.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst. 1990;82(15):1286–1289.

    Article  CAS  PubMed  Google Scholar 

  36. Russo IH, Koszalka M, Gimotty PA, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcino-genesis. Br J Cancer. 1990;62(2):243–247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis. 1990;11(10):1849–1855.

    Article  CAS  PubMed  Google Scholar 

  38. Russo IH, Russo J. Hormonal approach to breast cancer prevention. J Cell Biochem. 2000;34:1–6.

    Article  CAS  Google Scholar 

  39. Jannssens JP, Russo J, Russo IH, et al. Human chorionic gonadotropin (hCG) and prevention of breast cancer. Mol Cell Endocrinol. 2007;269(1-2):93–98.

    Article  CAS  Google Scholar 

  40. Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcino-genesis. Br J Cancer. 1991;64(3):481–484.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 1994;3(4):353–364.

    CAS  PubMed  Google Scholar 

  42. Russo J, Russo IH. The etiopathogenesis of breast cancer prevention. Cancer Lett. 1995;90(1):81–89.

    Article  CAS  PubMed  Google Scholar 

  43. Key TJA, Pike MC. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988;24(1):29–43.

    Article  CAS  PubMed  Google Scholar 

  44. Anderson TJ, Batterby S, King RJ, McPherson K, Going JJ. Oral contraceptive use influences breast proliferation. Human Pathol. 1989;20(12):1139–1144.

    Article  CAS  Google Scholar 

  45. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995;87:190–197.

    Article  CAS  PubMed  Google Scholar 

  46. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol. 2004;51(1):55–67.

    Article  PubMed  Google Scholar 

  47. Kocdor H, Kocdor MA, Russo J, et al. Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells. Cell Biol Intl. 2009;33(11):1135–1143.

    Article  CAS  Google Scholar 

  48. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A. 1999;96(5):2520–2525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Tao YX, Lei ZM, Rao CV. The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands. Life Sci. 1997;60(15):1297–1303.

    Article  CAS  PubMed  Google Scholar 

  50. Potten CS, Watson RJ, Williams CT, et al. The effect of age and menstrual cycle upon proliferation activity of the normal human breast. Br J Cancer. 1988;58(2):163–168.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2(1):65–73

    Article  Google Scholar 

  52. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990;62(3):244–278

    CAS  PubMed  Google Scholar 

  53. Russo J, Russo IH. Role of differentiation in the pathogenesis and prevention of breast cancer. J Endocrinol. 1997;4:7–21.

    CAS  Google Scholar 

  54. Tay LK, Russo J. Effect of human chorionic gonadotropin on 7, 12-dimethylbenz(a) anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Chem Biol Interact. 1985;55(1-2):13–21.

    Article  CAS  PubMed  Google Scholar 

  55. Alvarado MV, Russo J, Russo IH. Immunolocalization of inhibin in the mammary gland of rats treated with hCG. J Histochem Cytochem. 1993;41(1):29–34.

    Article  CAS  PubMed  Google Scholar 

  56. Alvarado MV, Hot TY, Russo J, Russo IH. Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and mammary gland of rat. Endocrine. 1994;2:1107–1114.

    CAS  Google Scholar 

  57. Alvarado MV, Alvarado NE, Russo J, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In vitro Cell Dev Boil Anim. 1994;30A(1):4–8.

    Article  CAS  Google Scholar 

  58. Ho TY, Russo J, Russo IH. Polypeptide pattern of human breast epithelial cells following human chorionic gonadotropin (hCG) treatment. Electrophoresis. 1994;15(5):746–750.

    Article  CAS  PubMed  Google Scholar 

  59. Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes C×26 and C×43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Diff. 1996;7(7):861–870.

    CAS  PubMed  Google Scholar 

  60. Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis. 1997;18(9):1799–1808.

    Article  CAS  PubMed  Google Scholar 

  61. Huynh H. In vivo regulation of the insulin-like growth factor system of mitogens by human chorionic gonadotropin. Int J Oncol. 1998;13(3):571–575.

    CAS  PubMed  Google Scholar 

  62. Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res. 1998;18(6A):4003–4010.

    CAS  PubMed  Google Scholar 

  63. You S, Tu ZJ, Kiang DT. Direct modulation of tumor suppressor connexin 26 gene by human chorionic gonadotropin in rat mammary gland. Cancer Res. 1998;58(7):1498–1502.

    CAS  PubMed  Google Scholar 

  64. Huang Y, Bove B, Wu Y, Russo IH, Yang X, Russo J. Micro-satellite instability during the immortalization and transformation of human breast epithelial cells in vitro. Mol Carcinog. 1999;24(2):118–127.

    Article  CAS  PubMed  Google Scholar 

  65. Srivastava P, Russo J, Russo IH. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Mol Carcinog. 1999;26(1):10–19.

    Article  CAS  PubMed  Google Scholar 

  66. Lei ZM, Rao ChV. Protective role of human chorionic gonadotropin and luteinizing hormone against breast cancer. In: Barnea ER, Jauniaux E, Schwarts PE, s. Cancer & Pregnancy. Totowa, NJ, USA: Springer; 2001:209–215.

    Chapter  Google Scholar 

  67. Sachdev D, Yee D. The IGF system and breast cancer. Endocrine Relat Cancer. 2001;8(3):197–209.

    Article  CAS  Google Scholar 

  68. Liao XH, Wang Y, Wang N, et al. Human chorionic gonadotropin decreases human breast cancer cell proliferation and promotes differentiation. IUBMB Life. 2014;66(5):352–360.

    Article  CAS  PubMed  Google Scholar 

  69. Srivastava P, Silva ID, Russo J, Mgbonyebi OP, Russo IH. Identification of new genes differentially expressed in breast carcinoma in breast carcinoma cells treated with human chorionic gonadotropin. Int J Oncol. 1998;13(3):465–469.

    CAS  PubMed  Google Scholar 

  70. Guo S, Russo IH, Lareef MH, Russo J. Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol. 2004;24(2):399–407.

    CAS  PubMed  Google Scholar 

  71. Balogh GA, Heulings R, Mailo DA, et al. Genomic signature induced by pregnancy in the human breast. Int J Oncol. 2006;28(2):399–410.

    CAS  PubMed  Google Scholar 

  72. Russo J, Balogh GA, Heulings R, et al. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev. 2006;15(4):306–342.

    Article  CAS  PubMed  Google Scholar 

  73. Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev. 2008;17(1):51–66.

    Article  CAS  PubMed  Google Scholar 

  74. Belitskaya-Levy I, Zeleniuch-Jacquotte A, Russo J, et al. Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res. 2011;4(9):1457–1464.

    Article  Google Scholar 

  75. Russo J, Russo IH. Molecular basis of pregnancy-induced breast cancer prevention. Horm Mol Biol Clin Invest. 2012;9(1):3–10.

    Article  CAS  Google Scholar 

  76. Peri S, Lopez de Cicco R, Santucci-Pereira J, et al. Defining the genomic signature of the parous breast. BMC Med Genomic. 2012;5:46.

    Article  CAS  Google Scholar 

  77. Russo J, Santucci-Pereira J, Lopez de Cicco R, et al. Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. Int J Cancer. 2012;131(5):1059–1070.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Russo J, Santucci-Pereira J, Russo IH. The genomic signature of breast cancer prevention. Genes (Basel). 2014;5(1):65–83.

    Article  CAS  Google Scholar 

  79. Lojun S, Bao S, Lei ZM, Rao CV. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol Reprod. 1997;57(5):1202–1210.

    Article  CAS  PubMed  Google Scholar 

  80. Rao CV, Li X, Manna SK, Lei ZM, Aggarwal BB. Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-B and AP-1 activation. J Biol Chem. 2004;279(24):25503–25510.

    Article  CAS  PubMed  Google Scholar 

  81. Lopez D, Sekharam M, Coppola D, Carter B. Purifies human chorionic gonadotropin induces apoptosis in breast cancer. Mol Cancer Ther. 2008;7(9):2837–2844.

    Article  CAS  PubMed  Google Scholar 

  82. Meduri G, Charnaux N, Spyratos F, Hacene K, Loosfelt H, Milgrom E. Luteinizing hormone receptor status and clinical pathologic, and prognostic features in patients with breast carcinomas. Cancer. 2003;97(7):1810–1816.

    Article  CAS  PubMed  Google Scholar 

  83. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981;50:465–495.

    Article  CAS  PubMed  Google Scholar 

  84. Lapthorn AJ, Harris DC, Littlejohn A, et al. Crystal structure of human chorionic gonadotropin. Nature. 1994;369(6480):455–461.

    Article  CAS  PubMed  Google Scholar 

  85. Walker RA. Significance of alpha-subunit hCG demonstrated in breast carcinoma by the immunoperoxidase technique. J Clin Pathol. 1978;31(3):245–249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Wachner R, WIttekind C, Von Kleist S. Immunohistological localization of beta-hCG in breast carcinomas. Eur J Cancer Clin Oncol. 1984;20(5):679–684.

    Article  CAS  PubMed  Google Scholar 

  87. Agnantis NJ, Patra F, Khaldi L, FIlis S. Immunohistochemical expression of subunit beta hCG in breast cancer. Eur J Gynaecol Oncol. 1992;13(6):461–466.

    CAS  PubMed  Google Scholar 

  88. Bieche I, Lazar V, Nogues C, et al. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma. Clin Cancer Res. 1998;4(3):671–676.

    CAS  PubMed  Google Scholar 

  89. Span PN, Manders P, Hauvel JJ, et al. Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-beta-3, -5 and -8 mRNAs has prognostic value in breast cancer. Clin Chem. 2003;49(7):1074–1080.

    Article  CAS  PubMed  Google Scholar 

  90. Chang E, Lee E, Oh SJ, Kim JS, Kang C. The immunoexpressions and prognostic significance of inhibin alpha and beta human chorionic gonadotrophins (hCG) in breast carcinomas. Cancer Res Treat. 2005;37(4):241–246.

    Article  PubMed  PubMed Central  Google Scholar 

  91. McFarland KC, Sprengel R, Phillips HS, et al. Lutropin-choriogonadotropin receptors: an unusual member of the G protein-coupled receptor family. Science. 1989;245(4917):494–495.

    Article  CAS  PubMed  Google Scholar 

  92. Loosfelt H, Misrahi M, Atger M, et al. Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. Science. 1989;245(4917):525–528.

    Article  CAS  PubMed  Google Scholar 

  93. Rao CV. Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta Endocrinol (Copenh). 1979;90(4):696–710.

    Article  CAS  Google Scholar 

  94. Casarini L, Lispi M, Longobardi S, et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signaling. PLoS One. 2012;7(10):e46682.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Rao CV. There is no turning back on the paradigm shift on the actions of human chorionic gonadotropin and luteinizing hormone. J Reprod Health Med. 2016;2(1):4–10.

    Article  Google Scholar 

  96. Pabon JE, Bird JS, Li X, et al. Human skin contains luteinizing hormone/chorionic gonadotropin receptors. J Clin Endocrinol Metab. 1996;81(7):2738–2741.

    CAS  PubMed  Google Scholar 

  97. Bird J, Li X, Lei ZM, Sanfilippo J, Yussman MA, Rao CV. Luteinizing hormone and human chorionic gonadotropin decrease type 2 5 α-reductase and androgen receptor protein levels in women’s skin. J Clin Endocrinol Metab. 1998;83(5):1776–1782.

    CAS  PubMed  Google Scholar 

  98. Meduri G, Charnaux N, Loosfelt H, et al. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res. 1997;57(5):857–864.

    CAS  PubMed  Google Scholar 

  99. Jiang X, Russo IH, Russo J. Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells. Int J Oncol. 2002;20(4):735–738.

    CAS  PubMed  Google Scholar 

  100. Kuijper TM, Ruigrok-Ritstier K, Verhoef-Post M, et al. LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment. Mol Cell Endocrinol. 2009;302(1):58–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Hu YL, Lei ZM, Huang ZH, Rao CV. Determinants of transcription of the chorionic gonadotropin/luteinizing hormone receptor gene in human breast cells. Breast J. 1999;5(3):186–193.

    Article  CAS  PubMed  Google Scholar 

  102. Cho-Chung YS, Clair T, Bodwin JS, Berghoffer B. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science. 1981;214(4516):77–99.

    Article  CAS  PubMed  Google Scholar 

  103. Bodek G, Rahman NA, Zaleska M, et al. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. Breast Cancer Res Treat. 2003;79(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  104. Gebauer G, Fehm T, Beck EP, Berkholz A, Licht P, Jager W. Cytotoxic effect of conjugates of doxorubicin and human chorionic gonadotropin (hCG) in breast cancer cells. Breast Cancer Res Treat. 2003;77(2):125–131.

    Article  CAS  PubMed  Google Scholar 

  105. Millilken EL, Ameduri RK, Landis MD, Behrooz A, Abdul-Karim FW, Keri RA. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology. 2002;143(9):3671–3680.

    Article  CAS  Google Scholar 

  106. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology. 2002;143(10):4084–4095.

    Article  CAS  PubMed  Google Scholar 

  107. Srisuparap S, Strakova Z, Brudney A, et al. Signal transduction pathway activated by chorionic gonadotropin in the primate endometrial epithelial cells. Biol Reprod. 2003;68(2):457–464.

    Article  CAS  Google Scholar 

  108. Lei ZM, Yang M, Li X, Takikawa O, Rao CV. Upregulation of placental indoleamine 2, 3-dioxygenase by human chorionic gonadotropin. Biol Reprod. 2006;76(4):639–644.

    Article  PubMed  CAS  Google Scholar 

  109. So KH, Kodithuwakku SP, Li RH, et al. Human chorionic gonadotropin stimulates spheroid attachment on fallopian tube epithelial cells through the mitogen-activated protein kinase pathway and down-regulation of olfactomedin-1. Fertil Steril. 2015;104(2):474–482.

    Article  CAS  PubMed  Google Scholar 

  110. Rao CV, Lei ZM. Consequences of targeted inactivation of LH receptors. Mol Cell Endocrinol. 2002;187(1-2):57–67.

    Article  CAS  PubMed  Google Scholar 

  111. Grubbs CJ, Peckham JC, McDonough KD. Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea induced mammary cancer. Anticancer Res. 1988;4:495–497.

    Google Scholar 

  112. Santucci-Pereira J, George C, Armiss D, et al. Mimicking pregnancy as a strategy for breast cancer prevention. Breast Cancer Manag. 2013;2(4):283–294.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1995;4(5):437–440.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cellular Biology and Pharmacology, Reproduction and Development Program, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, 33199, USA

    C. V. Rao PhD

  2. Department of Molecular and Human Genetics, Reproduction and Development Program, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA

    C. V. Rao PhD

  3. Department of Obstetrics and Gynecology, Reproduction and Development Program, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA

    C. V. Rao PhD

Authors
  1. C. V. Rao PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. V. Rao PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rao, C.V. Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease?. Reprod. Sci. 24, 1102–1110 (2017). https://doi.org/10.1177/1933719116676396

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116676396

Keywords

Search

Navigation